Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide Effect on Saliva in Healthy Volunteers
NCT05340192Phase 1Completed
- Sponsor
- Duke University
- Start
- Sep 2019
- Primary completion
- Feb 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of octreotide in pharyngocutaneous fistula (PCF), sponsored by Duke University. Primary endpoint: Change of saliva proteomes of subjects pre- and post-octreotide treatment at Day 1. Started Sep 2019; status: completed.
02
Drugs
octreotide
03
Conditions
pharyngocutaneous fistula (PCF)
Beyond the preview
Go deeper on NCT05340192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05340192.